Skip to main content
SpringerLink
Log in

Compared with amisulpride, treatment of schizophrenia with olanzapine is associated with a greater increase in body weight and blood glucose

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Peuskens J, De Hert M, Mortimer A, SOLIANOL Study Group.Metabolic control in patients with schizophrenia treated with amisulpride or olanzapine. International Clinical Psychopharmacology 22: 145-152, No. 3, May 2007

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Compared with amisulpride, treatment of schizophrenia with olanzapine is associated with a greater increase in body weight and blood glucose. React. Wkly. 1156, 2 (2007). https://doi.org/10.2165/00128415-200711560-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-200711560-00004

Keywords

Search

Navigation